Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.
(Q43222714)
scientific article published on 15 December 2009
scientific article published on 15 December 2009
Language:
Current Data About
Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.
other details
| description | scientific article published on 15 December 2009 |
External Links
| (P356) |
10.1158/1078-0432.CCR-09-1204
|
| (P698) |
20008840
|